BIOVISION ANNOUNCES ITS FIRST BIOVISION INVESTOR CONFERENCE March 25-26, 2013 – LYON, France
Venerdì 21 Dicembre 2012 14:31
PDF Stampa E-mail

The Selection Committee is composed with top-notch international investors from 9 different countries.
Roman Fleck, Principal, Index Ventures, a venture capital investment firm based in Geneva, Switzerland, will be chairing the Selection Committee.

Roman Fleck, comments: "This is a unique event in Europe that will showcase both the future industry leaders and the VC-backed leading start-up companies in one single event.  The Selection Committee is happy to contribute and lead the gathering of the best European start-up companies in the Life Sciences.”

Didier Hoch, Executive Chairman, BIOVISION, comments:
“We are delighted to bring our proven experience and unique network of international decision-makers in Life Sciences to build this high-level investment conference in Europe. This initiative will allow us to demonstrate the contribution of BIOVISION in helping start-up companies finance their projects. The quality of the Selection Committee reflects the ambition of the BIOVISION Investor Conference. It also underscores our commitment to fostering innovation while supporting the growth of Life Sciences start-up companies.


BIOVISION INVESTOR CONFERENCE SELECTION COMMITTEE

Alain

Huriez

Advent Venture Partners

Marcel

Kloosterman

DSM Venturing

Lukas

Guenther

Wellington Partners Venture Capital

Ivica

Cerina

NGN Capital

Thom

Rasche

Earlybird Venture Capital

Jesus

Martin-Garcia

Eclosion

Diego

Braguglia

VI Partners AG

Angelo

De Rosa

Medtronic Europe

Sven

Rohmann

Burrill & Company

Manus

Rogan

Fountain Health Partners

Daniel

O'Mahony

Seroba Kernel

Celia

Hart

CEA Investissements

Isabelle

de Cremoux

Seventure

Franck

Lescure

Auriga Partners

Marie-Laure

Guarrigues

CDC entreprises

François

Valencony

Merieux Developpement

Françcois

Miceli

Sofimac

Joey

Mason

Delta Partners

Ilka

Wicke

Boehringer Ingelheim Venture Fund

Maciek

Drozdz

Entrepreneurs Fund Management LLP

Mark

Redshaw

Evonik Corporate Venturing

Claus

Andersson

Sunstone Capital

Maurizio

PetitBon

Kreos Capital

Hans

Kuepper

Global Life Sciences Ventures

Christina

Takke

Forbion Capital Partners

Jasper

Bos

Merck Serono Ventures

Davide

Turco

Altante Ventures (IntesaSanPaolo)

Muriel

Bekto

LifeScan J&J

Alexandra

Goll

TVM Capital

Aris

Constandinides

NBGI Ventures

Mark

Wilson

GlaxoSmithKline Pharmaceuticals

Antoine

Papiernik

Sofinnova Partners

Gérard

Hascoet

MDStart

Renee

Aguiar-Lucander

Omega Funds




About BIOVISION

BIOVISION is organized since 1999 in Lyon by the Fondation pour l’Université de Lyon, an independent non-profit organization. BIOVISION brings together top decision-makers from the academic, private, policy-making and civil society sectors to translate innovative ideas into actionable solutions for the benefit of citizens. The next edition of the BIOVISION World Life Sciences Forum will be held March 24-26, 2013 in Lyon, France. It expects more than 3,000 participants from 60 different countries, and 100 media representatives.  BIOVISION is the place where key stakeholders debate over the impact of the latest scientific advances on society and share a prospective vision on how to overcome health, environment and nutrition challenges.
More information on BIOVISION, the World Life Sciences Forum, at www.BIOVISION.org.

BIOVISION ANNOUNCES ITS FIRST BIOVISION INVESTOR CONFERENCE March 25-26, 2013 – LYON, France


MEDIA CONTACT:
BIOVISION, the World Life Sciences Forum
Souad Gara
Communications Director
Phone: (33) 4 78 92 70 19
Mobile: (33) 6 20 51 68 37
Email: Questo indirizzo e-mail è protetto dallo spam bot. Abilita Javascript per vederlo.

Read more http://feedproxy.google.com/~r/biopmed-news/~3/5gPxsorgwFA/index.php